The PE Ratio as of December 2024 (TTM) for Mainz Biomed B.V. (MYNZ) is -0.11

According to Mainz Biomed B.V.’s latest financial reports and current stock price. The company's current PE Ratio is -0.11. This represents a change of -94.93% compared to the average of -2.17 of the last 4 quarters.

Mainz Biomed B.V. (MYNZ) Historical PE Ratio (quarterly & annually)

How has MYNZ PE Ratio performed in the past?

The mean historical PE Ratio of Mainz Biomed B.V. over the last ten years is -34.70. The current -0.11 PE Ratio has changed -68.30% with respect to the historical average. Over the past ten years (40 quarters), MYNZ's PE Ratio was at its highest in in the December 2023 quarter at -1.18. The PE Ratio was at its lowest in in the March 2021 quarter at -750.02.

Mainz Biomed B.V. (MYNZ) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Mainz Biomed B.V. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Mainz Biomed B.V. (MYNZ) Average PE Ratio

How has MYNZ PE Ratio performed in the past?

The current PE Ratio of Mainz Biomed B.V. (MYNZ) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Mainz Biomed B.V. (MYNZ) PE Ratio vs. Peers

How is MYNZ’s PE Ratio compared to its peers?

Mainz Biomed B.V.’s PE Ratio is less than Applied DNA Sciences, Inc. (-0.10), greater than Neuronetics, Inc. (-1.21), greater than Prenetics Global Limited (-1.51), less than FONAR Corporation (9.92), less than Genetron Holdings Limited (0), greater than Olink Holding AB (publ) (-96.25), greater than MDxHealth SA (-2.40), greater than Inotiv, Inc. (-1.09), greater than Star Equity Holdings, Inc. (-0.98), greater than Standard BioTools Inc. (-5.46), greater than Biodesix, Inc. (-4.87), greater than ENDRA Life Sciences Inc. (-0.15), greater than Sera Prognostics, Inc. (-8.27), greater than DarioHealth Corp. (-0.82), greater than Burning Rock Biotech Limited (-1.14), less than LumiraDx Limited (-0.01),

Build a custom stock screener for Mainz Biomed B.V. (MYNZ) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Mainz Biomed B.V. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Mainz Biomed B.V. (MYNZ) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Mainz Biomed B.V. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.